LUND, SWEDEN--(Marketwire - March 18, 2010) -
CellaVision, which develops and sells digital morphology products
for the
routine analysis of blood and other body fluids, extends and
broadens
cooperation with Sysmex by entering a global distribution
agreement. The
agreement gives Sysmex a non-exclusive right to sell CellaVision's
products in
hematology laboratories worldwide.
"We extend our successful collaboration with Sysmex and enhance the
agreement to
comprise more markets, including Japan, the country of origin for
Sysmex
Corporation", says Yvonne Martensson, CEO of CellaVision. "Sysmex has the
global
leadership position within hematology, and we are extremely pleased that
they
continue to promote and sell our analyzers to their customers, providing us
with
a very strong sales channel and the ability to carry on our market
penetration.
Sysmex is the perfect partner and strategic match in our
commitment to
strengthen our position as world leader within digital morphology
analysis to
hematology laboratories."
Sysmex and CellaVision have been developing their partnership since 2001,
when
they partnered in the European market. Sysmex Corporation, based in Kobe,
Japan,
is a world leader in clinical laboratory testing for blood, urine and other
specimen. By adding CellaVision's products to their range, Sysmex can offer
their customers a complete line of automated laboratory instruments, that
is to
say instruments for every step of the analytical process, from sample
preparation to cell counters and final assessment in CellaVision's
analyzers.
Starting April 1, 2010, the non-exclusive agreement comprises all
international
markets but Canada.
CellaVision continues to sell direct through its own sales organizations
in the
Nordic countries, the US, Canada and Japan. In 2009, Europe accounted for
41% of
sales, North America for 55% and the rest of the world for 4%.
For more information, please contact:
Yvonne Martensson, CEO, CellaVision AB
Phone: + 708 33 77 82. E-mail: yvonne.martensson@cellavision.com
About Sysmex
Sysmex Corporation is a world leader in clinical laboratory
systemization and
solutions, including laboratory diagnostics, laboratory automation and
clinical
information systems. Serving customers for more than 42 years, Sysmex
focuses
on technological leadership in diagnostic science and information tools
that
make a real difference in the health of people worldwide. The
company,
headquartered in Kobe, Japan, has subsidiaries in North America, Latin
America,
Europe, China and Asia Pacific and employs more than 4,500 employees
worldwide.
Sysmex Corporation is listed in the top tier of the Tokyo Stock
Exchange. For
more information about Sysmex Corporation and its affiliate companies,
please
visit www.sysmex.com.
About CellaVision
CellaVision AB develops, markets, and sells market leading image analysis
based
systems for routine analysis of blood and other body fluids. The company
has a
core competence in development of software and hardware for automatic
image
analysis of cells and cell changes for applications in health and medical
care.
The company develops and markets systems for automatic differentials of
white
blood cells and red morphology, and software for education and quality
assurance
of differentials. The company's associates have expertise in advanced
imaging
analysis, artificial intelligence, and automated microscopy.
The company headquarters are in Lund, Sweden. The company also has
subsidiaries
in the US, Canada and Japan. For more information, visit
www.cellavision.com.
CellaVision's share is listed on First North Premier at the OMX Stockholm
Stock
Exchange. The company's Certified Advisor is Remium AB.
[HUG#1395029]
